Cargando…
An Oncolytic Adenovirus Encoding SA-4-1BBL Adjuvant Fused to HPV-16 E7 Antigen Produces a Specific Antitumor Effect in a Cancer Mouse Model
Human papillomaviruses (HPVs) are responsible for about 25% of cancer cases worldwide. HPV-16 E7 antigen is a tumor-associated antigen (TAA) commonly expressed in HPV-induced tumors; however, it has low immunogenicity. The interaction of 4-1BBL with its receptor induces pleiotropic effects on innate...
Autores principales: | Martinez-Perez, Alejandra G., Perez-Trujillo, Jose J., Garza-Morales, Rodolfo, Ramirez-Avila, Norma E., Loera-Arias, Maria J., Gomez-Gutierrez, Jorge G., Saucedo-Cardenas, Odila, Garcia-Garcia, Aracely, Rodriguez-Rocha, Humberto, Montes-de-Oca-Luna, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917608/ https://www.ncbi.nlm.nih.gov/pubmed/33673295 http://dx.doi.org/10.3390/vaccines9020149 |
Ejemplares similares
-
A DNA Vaccine Encoding SA-4-1BBL Fused to HPV-16 E7 Antigen Has Prophylactic and Therapeutic Efficacy in a Cervical Cancer Mouse Model
por: Garza-Morales, Rodolfo, et al.
Publicado: (2019) -
4-1BBL as a Mediator of Cross-Talk between Innate, Adaptive, and Regulatory Immunity against Cancer
por: Martinez-Perez, Alejandra G., et al.
Publicado: (2021) -
Phosphorylated α-Synuclein-Copper Complex Formation in the Pathogenesis of Parkinson's Disease
por: Castillo-Gonzalez, Juan Antonio, et al.
Publicado: (2017) -
DNA vaccine encoding human papillomavirus antigens flanked by a signal peptide and a KDEL sequence induces a potent therapeutic antitumor effect
por: Perez-Trujillo, Jose J., et al.
Publicado: (2017) -
Antioxidant Therapeutics in Parkinson’s Disease: Current Challenges and Opportunities
por: Duarte-Jurado, Ana Patricia, et al.
Publicado: (2021)